Thomas V Osborne

US Patent:

20130086178, Apr 4, 2013

Filed:

Sep 30, 2011

Appl. No.:

13/249765

Inventors:

Thomas Ernest Osborne - Philadelphia PA, US
Eric Lee Chin-Sang - Seattle WA, US
Paul Leonard Kompfner - Seattle WA, US
Chad Steven Estes - Woodinville WA, US
Rahul Sudhir Kumar - Kirkland WA, US
Michael Joseph Papale - Seattle WA, US
Urja Madhukar Shah - Bellevue WA, US
Ionut Ciprian Gradinaru - Sammamish WA, US
Brian Ka-Hing Fung - Bellevue WA, US

Assignee:

Microsoft Corporation - Redmond WA

International Classification:

G06F 15/16

US Classification:

709206

Abstract:

One or more techniques and/or systems are disclosed for identifying an in-application message to display to a user. A user may perform a user action in an application, which can be identified. The identified user action can be compared to metadata data associated with a plurality of in-application messages for the application, and an in-application message that is eligible for display to the user can be identified based on the user action. A determination can be made whether to display the eligible message to the user in the application, based upon one or more in-application messages that the user may have previously viewed, as may be found or tracked in a user message viewing history.

US Patent:

52212696, Jun 22, 1993

Filed:

Oct 15, 1990

Appl. No.:

7/597575

Inventors:

Richard H. Miller - Pittsburgh PA
Brian L. Bates - Bloomington IN
Todd A. Hall - Bloomington IN
Thomas A. Osborne - Bloomington IN

Assignee:

Cook Incorporated - Bloomington IN

International Classification:

A61M 2500

US Classification:

604281

Abstract:

A medical device for localizing a nonpalpable breast lesion. The device includes a tubular introducer needle and a wire guide positioned therein for inserting into a breast to the site of the lesion. The wire guide includes a distal portion having a preformed, resilient helical coil configuration for locking into position about the lesion. The distal portion includes a superelastic metallic alloy for maintaining the helical coil configuration after repeated extensions from and retractions into the needle passageway. The needle is inserted with the wire guide positioned therein into the breast to the site of the lesion and from the distal portion of the needle. The distal end of the needle includes a plurality of indentations for enhancing the ultrasound visualization thereof. As the distal portion of the wire guide emerges from the needle, the acuate distal end of the wire guide cuts into and scribes a helical path about the tissue distal to the lesion. The remainder of the distal portion of the wire guide follows the path scribed by the acuate distal tip and locks about the tissue distal to the lesion.